MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-13-2025
Venus Concept Total Non Current Liabilities 2011-2026 | VERO
Annual Total Non Current Liabilities Venus Concept
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 35.1 M | 75.9 M | 77 M | 81.1 M | 84.2 M | 68.8 M | 20 M | 5.73 M | 150 M | 144 M | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 150 M | 5.73 M | 74.2 M |
Quarterly Total Non Current Liabilities Venus Concept
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 7.84 M | 19.2 M | 25.1 M | 35.1 M | 34.2 M | 46.8 M | 77.5 M | 75.9 M | 84.3 M | 76.8 M | 76.8 M | 77 M | 81.1 M | 81.2 M | 81.4 M | 81.1 M | 80.2 M | 79.8 M | 83.7 M | 84.2 M | 84.2 M | 84.2 M | 84.2 M | 66.3 M | 66.3 M | 66.3 M | 66.3 M | 58.6 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 84.3 M | 7.84 M | 66.6 M |
Total Non Current Liabilities of other stocks in the Medical devices industry
| Issuer | Total Non Current Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
EDAP TMS S.A.
EDAP
|
7.44 M | $ 3.22 | -2.57 % | $ 121 M |  France |
 |
Align Technology
ALGN
|
184 M | $ 189.61 | -0.56 % | $ 14.2 B |  USA |
 |
Axonics Modulation Technologies
AXNX
|
24.8 M | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
35.2 M | - | 1.37 % | $ 20.5 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
85.2 M | - | - | $ 1.77 B | USA |
 |
Avinger
AVGR
|
12.7 M | - | -20.74 % | $ 369 K | USA |
 |
AdaptHealth Corp.
AHCO
|
424 M | $ 12.8 | 0.55 % | $ 1.73 B | USA |
 |
BIOLASE
BIOL
|
5.69 M | - | -13.19 % | $ 166 K | USA |
 |
Allied Healthcare Products
AHPI
|
115 K | - | 3.58 % | $ 2.21 M | USA |
 |
BioSig Technologies
BSGM
|
103 K | - | 37.08 % | $ 85.7 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
906 K | - | -5.86 % | $ 30.6 M | USA |
 |
Conformis
CFMS
|
29.2 M | - | - | $ 16.4 M | USA |
 |
Helius Medical Technologies
HSDT
|
252 K | $ 2.16 | 4.85 % | $ 1.31 M | USA |
 |
Cardiovascular Systems
CSII
|
28.3 M | - | 0.15 % | $ 844 M | USA |
 |
Cytosorbents Corporation
CTSO
|
14 M | $ 0.63 | -3.04 % | $ 39.2 M | USA |
 |
Apollo Endosurgery
APEN
|
59 M | - | - | $ 475 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
116 M | $ 16.19 | -0.12 % | $ 380 M | USA |
 |
ClearPoint Neuro
CLPT
|
23.9 M | $ 11.78 | 9.58 % | $ 334 M | USA |
 |
LivaNova PLC
LIVN
|
516 M | $ 64.2 | -1.45 % | $ 3.5 B |  Britain |
 |
Dynatronics Corporation
DYNT
|
10 M | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
161 M | - | - | $ 10.2 M | USA |
 |
Pulmonx Corporation
LUNG
|
25 M | $ 1.27 | -0.78 % | $ 51.7 M | USA |
 |
CryoLife, Inc.
CRY
|
400 M | - | -4.14 % | $ 702 M | USA |
 |
Electromed
ELMD
|
8.87 K | $ 26.39 | 3.57 % | $ 223 M | USA |
 |
Second Sight Medical Products
EYES
|
2.36 M | - | -0.97 % | $ 54.4 M | USA |
 |
Soliton, Inc.
SOLY
|
4.28 K | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
568 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
3.08 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
39.9 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
8.24 M | - | - | $ 111 M |  Canada |
 |
Globus Medical
GMED
|
18.2 M | $ 94.87 | 0.52 % | $ 12.8 B | USA |
 |
Orthofix Medical
OFIX
|
83.1 M | $ 12.35 | 1.65 % | $ 489 M |  Curacao |
 |
Intersect ENT, Inc.
XENT
|
116 M | - | - | $ 955 M | USA |
 |
Delcath Systems
DCTH
|
2.52 M | $ 10.84 | 1.88 % | $ 388 M | USA |
 |
IRIDEX Corporation
IRIX
|
2.33 M | $ 1.06 | 0.95 % | $ 18 M | USA |
 |
Insulet Corporation
PODD
|
1.06 B | $ 189.56 | -1.38 % | $ 13.3 B | USA |
 |
CONMED Corporation
CNMD
|
877 M | $ 38.34 | 2.24 % | $ 1.19 B | USA |
 |
Inspire Medical Systems
INSP
|
24.6 M | $ 56.31 | -0.07 % | $ 1.65 B | USA |
 |
Integer Holdings Corporation
ITGR
|
1.02 B | $ 86.02 | 1.37 % | $ 2.99 B | USA |
 |
PAVmed
PAVM
|
300 K | $ 9.0 | -1.85 % | $ 6.03 M | USA |
 |
Invacare Corporation
IVC
|
325 M | - | - | $ 24.7 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
1.44 B | $ 84.15 | 5.56 % | $ 49.2 B | USA |
 |
LENSAR
LNSR
|
3.44 M | $ 5.09 | -3.23 % | $ 60.9 M | USA |
 |
Sintx Technologies
SINT
|
1.76 M | $ 2.47 | -1.59 % | $ 6.85 M | USA |
 |
MiMedx Group
MDXG
|
65.4 M | $ 3.43 | 2.39 % | $ 507 M | USA |
 |
Stryker Corporation
SYK
|
13 B | $ 327.51 | -0.65 % | $ 125 B | USA |